Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases-Reference-Cited by-同舟云学术

Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases

Published:2012-10 Issue:10 Volume:23 Page:2585-2591
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

de Boer M.,Adang E.M.M.,Van Dycke K.C.G.,van Dijck J.A.A.M.,Borm G.F.,Seferina S.C.,van Deurzen C.H.M.,van Diest P.J.,Bult P.,Donders A.R.T.,Tjan-Heijnen V.C.G.

Funder

Netherlands Organization for Health Research and Development

Dutch Breast Cancer Trialists Group

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/10/2585/13786149/mds051.pdf

Reference36 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. The costs of breast cancer prior to and following diagnosis;Broekx;Eur J Health Econ,2011

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet,2005

4. Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancer;Messori;Eur J Clin Pharmacol,1996

5. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package;Kattlove;JAMA,1995

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Radiotherapy Options in Breast Cancer: Does Intraoperative Radiotherapy Represent the Most Cost-Efficacious Option?;Clinical Breast Cancer;2014-04